Latest for Halda Therapeutics

Advancing Hope for Prostate Cancer Patients: Johnson & Johnson Acquires Halda for $3.05B
Highlight

Advancing Hope for Prostate Cancer Patients: Johnson & Johnson Acquires Halda for $3.05B

Congrats From Canaan Partners! Canaan congratulates Canaan GP Tim Shannon, Canaan EIR Chris Schade, Halda Scientific founder Craig Crews, and the entire Halda team on the announcement of Halda's acquisition by Johnson & Johnson. 
When Cancer Learns to Work Around the Drug
Highlight

When Cancer Learns to Work Around the Drug

Halda Therapeutics developed a new class of oral cancer medicines designed to selectively kill tumor cells by turning cancer’s own biology against it.